![Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies](https://www.mdpi.com/cancers/cancers-14-05473/article_deploy/html/images/cancers-14-05473-g001.png)
Cancers | Free Full-Text | Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
![Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy](https://www.cell.com/cms/attachment/f15f10ba-24ab-43c4-94b1-06ab90bec4ed/gr1_lrg.jpg)
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy
![Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/0ae1a419-8c04-4e6e-8a98-2b83b3eaa1d8/gr1.gif)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology
![Emerging trends in immunotherapy for pediatric sarcomas | Journal of Hematology & Oncology | Full Text Emerging trends in immunotherapy for pediatric sarcomas | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-019-0756-z/MediaObjects/13045_2019_756_Fig1_HTML.png)
Emerging trends in immunotherapy for pediatric sarcomas | Journal of Hematology & Oncology | Full Text
![Frontiers | The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review Frontiers | The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review](https://www.frontiersin.org/files/Articles/1044707/fonc-12-1044707-HTML/image_m/fonc-12-1044707-g001.jpg)
Frontiers | The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review
![Biomedicines | Free Full-Text | Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype Biomedicines | Free Full-Text | Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype](https://pub.mdpi-res.com/biomedicines/biomedicines-11-00874/article_deploy/html/images/biomedicines-11-00874-ag.png?1679640819)
Biomedicines | Free Full-Text | Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype
![Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice](https://www.mdpi.com/cancers/cancers-13-02189/article_deploy/html/images/cancers-13-02189-g001.png)
Cancers | Free Full-Text | Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
![Cureus | A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review | Article Cureus | A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review | Article](https://assets.cureus.com/uploads/figure/file/246471/lightbox_c1747cb0f40611ebb741a9a1e985fb6f-Add-a-little-bit-of-body-text-12.png)